The U.S. genome editing market was valued at USD 3.49 billion in 2023 and is projected to reach USD 10.69 billion by 2030, growing at a CAGR of 16.5% from 2024 to 2030. This robust growth is primarily driven by increasing demand for synthetic genes, ...
